[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |
Advanced search

United States Opioid Induced Constipation (OIC) Drugs Market Report 2018

March 2018 | 107 pages | ID: U09FE4607BDQEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Opioid Induced Constipation (OIC) Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Opioid Induced Constipation (OIC) Drugs in these regions, from 2013 to 2025 (forecast).
United States Opioid Induced Constipation (OIC) Drugs market competition by top manufacturers/players, with Opioid Induced Constipation (OIC) Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • Ironwood Pharmaceuticals Inc
  • Daiichi Sankyo Co Ltd
  • Pfizer
  • Progenics Pharmaceuticals Inc
  • Shionogi & Co., Ltd
  • Allergan Plc
  • Nektar Therapeutics
  • Purdue Pharma
  • S.L.A. Pharma AG
  • Mundipharma International Limited
  • Ono Pharmaceutical Co., Ltd
  • Takeda Pharmaceutical Company Limited
  • Theravance Biopharma Inc
  • Valeant Pharmaceuticals International
  • Cosmo Pharmaceuticals SA
  • Daewoong Pharmaceutical
  • C.B. Fleet Company
  • Sucampo Pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • By Drug Type
    • Lubiprostone
    • Methyl Naltrexone Bromide
    • Naldemedine
    • Alvimopan
    • Other
  • By Prescription Type
    • Generic and Branded Prescribed Drugs
    • Over The Counter Drugs
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Opioid Induced Constipation (OIC) Drugs Market Report 2018

1 OPIOID INDUCED CONSTIPATION (OIC) DRUGS OVERVIEW

1.1 Product Overview and Scope of Opioid Induced Constipation (OIC) Drugs
1.2 Classification of Opioid Induced Constipation (OIC) Drugs by Product Category
  1.2.1 United States Opioid Induced Constipation (OIC) Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Opioid Induced Constipation (OIC) Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Lubiprostone
  1.2.4 Methyl Naltrexone Bromide
  1.2.5 Naldemedine
  1.2.6 Alvimopan
  1.2.7 Other
1.3 United States Opioid Induced Constipation (OIC) Drugs Market by Application/End Users
  1.3.1 United States Opioid Induced Constipation (OIC) Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Hospital Pharmacies
  1.3.3 Retail Pharmacies
  1.3.4 Online Pharmacies
1.4 United States Opioid Induced Constipation (OIC) Drugs Market by Region
  1.4.1 United States Opioid Induced Constipation (OIC) Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Opioid Induced Constipation (OIC) Drugs Status and Prospect (2013-2025)
  1.4.3 Southwest Opioid Induced Constipation (OIC) Drugs Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Opioid Induced Constipation (OIC) Drugs Status and Prospect (2013-2025)
  1.4.5 New England Opioid Induced Constipation (OIC) Drugs Status and Prospect (2013-2025)
  1.4.6 The South Opioid Induced Constipation (OIC) Drugs Status and Prospect (2013-2025)
  1.4.7 The Midwest Opioid Induced Constipation (OIC) Drugs Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Opioid Induced Constipation (OIC) Drugs (2013-2025)
  1.5.1 United States Opioid Induced Constipation (OIC) Drugs Sales and Growth Rate (2013-2025)
  1.5.2 United States Opioid Induced Constipation (OIC) Drugs Revenue and Growth Rate (2013-2025)

2 UNITED STATES OPIOID INDUCED CONSTIPATION (OIC) DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Opioid Induced Constipation (OIC) Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Opioid Induced Constipation (OIC) Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Opioid Induced Constipation (OIC) Drugs Average Price by Players/Suppliers (2013-2018)
2.4 United States Opioid Induced Constipation (OIC) Drugs Market Competitive Situation and Trends
  2.4.1 United States Opioid Induced Constipation (OIC) Drugs Market Concentration Rate
  2.4.2 United States Opioid Induced Constipation (OIC) Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Opioid Induced Constipation (OIC) Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES OPIOID INDUCED CONSTIPATION (OIC) DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Region (2013-2018)
3.2 United States Opioid Induced Constipation (OIC) Drugs Revenue and Market Share by Region (2013-2018)
3.3 United States Opioid Induced Constipation (OIC) Drugs Price by Region (2013-2018)

4 UNITED STATES OPIOID INDUCED CONSTIPATION (OIC) DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Opioid Induced Constipation (OIC) Drugs Revenue and Market Share by Type (2013-2018)
4.3 United States Opioid Induced Constipation (OIC) Drugs Price by Type (2013-2018)
4.4 United States Opioid Induced Constipation (OIC) Drugs Sales Growth Rate by Type (2013-2018)

5 UNITED STATES OPIOID INDUCED CONSTIPATION (OIC) DRUGS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Opioid Induced Constipation (OIC) Drugs Sales and Market Share by Application (2013-2018)
5.2 United States Opioid Induced Constipation (OIC) Drugs Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES OPIOID INDUCED CONSTIPATION (OIC) DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Ironwood Pharmaceuticals Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 Daiichi Sankyo Co Ltd
  6.2.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Pfizer
  6.3.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Pfizer Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Progenics Pharmaceuticals Inc
  6.4.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 Shionogi & Co., Ltd
  6.5.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Allergan Plc
  6.6.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Nektar Therapeutics
  6.7.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Purdue Pharma
  6.8.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 S.L.A. Pharma AG
  6.9.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Mundipharma International Limited
  6.10.2 Opioid Induced Constipation (OIC) Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview
6.11 Ono Pharmaceutical Co., Ltd
6.12 Takeda Pharmaceutical Company Limited
6.13 Theravance Biopharma Inc
6.14 Valeant Pharmaceuticals International
6.15 Cosmo Pharmaceuticals SA
6.16 Daewoong Pharmaceutical
6.17 C.B. Fleet Company
6.18 Sucampo Pharmaceuticals

7 OPIOID INDUCED CONSTIPATION (OIC) DRUGS MANUFACTURING COST ANALYSIS

7.1 Opioid Induced Constipation (OIC) Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Opioid Induced Constipation (OIC) Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES OPIOID INDUCED CONSTIPATION (OIC) DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Opioid Induced Constipation (OIC) Drugs Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Opioid Induced Constipation (OIC) Drugs Sales Volume Forecast by Type (2018-2025)
11.3 United States Opioid Induced Constipation (OIC) Drugs Sales Volume Forecast by Application (2018-2025)
11.4 United States Opioid Induced Constipation (OIC) Drugs Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.


LIST OF TABLES AND FIGURES

Figure Product Picture of Opioid Induced Constipation (OIC) Drugs
Figure United States Opioid Induced Constipation (OIC) Drugs Market Size (K Pcs) by Type (2013-2025)
Figure United States Opioid Induced Constipation (OIC) Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Lubiprostone Product Picture
Figure Methyl Naltrexone Bromide Product Picture
Figure Naldemedine Product Picture
Figure Alvimopan Product Picture
Figure Other Product Picture
Figure United States Opioid Induced Constipation (OIC) Drugs Market Size (K Pcs) by Application (2013-2025)
Figure United States Sales Market Share of Opioid Induced Constipation (OIC) Drugs by Application in 2017
Figure Hospital Pharmacies Examples
Table Key Downstream Customer in Hospital Pharmacies
Figure Retail Pharmacies Examples
Table Key Downstream Customer in Retail Pharmacies
Figure Online Pharmacies Examples
Table Key Downstream Customer in Online Pharmacies
Figure United States Opioid Induced Constipation (OIC) Drugs Market Size (Million USD) by Region (2013-2025)
Figure The West Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) and Growth Rate (2013-2025)
Figure United States Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Opioid Induced Constipation (OIC) Drugs Market Major Players Product Sales Volume (K Pcs) (2013-2018)
Table United States Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table United States Opioid Induced Constipation (OIC) Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Opioid Induced Constipation (OIC) Drugs Sales Share by Players/Suppliers
Figure 2017 United States Opioid Induced Constipation (OIC) Drugs Sales Share by Players/Suppliers
Figure United States Opioid Induced Constipation (OIC) Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Opioid Induced Constipation (OIC) Drugs Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Opioid Induced Constipation (OIC) Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Opioid Induced Constipation (OIC) Drugs Revenue Share by Players/Suppliers
Table United States Market Opioid Induced Constipation (OIC) Drugs Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)
Figure United States Market Opioid Induced Constipation (OIC) Drugs Average Price (USD/Pcs) of Key Players/Suppliers in 2017
Figure United States Opioid Induced Constipation (OIC) Drugs Market Share of Top 3 Players/Suppliers
Figure United States Opioid Induced Constipation (OIC) Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Opioid Induced Constipation (OIC) Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Opioid Induced Constipation (OIC) Drugs Product Category
Table United States Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Region (2013-2018)
Table United States Opioid Induced Constipation (OIC) Drugs Sales Share by Region (2013-2018)
Figure United States Opioid Induced Constipation (OIC) Drugs Sales Share by Region (2013-2018)
Figure United States Opioid Induced Constipation (OIC) Drugs Sales Market Share by Region in 2017
Table United States Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Opioid Induced Constipation (OIC) Drugs Revenue Share by Region (2013-2018)
Figure United States Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region (2013-2018)
Figure United States Opioid Induced Constipation (OIC) Drugs Revenue Market Share by Region in 2017
Table United States Opioid Induced Constipation (OIC) Drugs Price (USD/Pcs) by Region (2013-2018)
Table United States Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Type (2013-2018)
Table United States Opioid Induced Constipation (OIC) Drugs Sales Share by Type (2013-2018)
Figure United States Opioid Induced Constipation (OIC) Drugs Sales Share by Type (2013-2018)
Figure United States Opioid Induced Constipation (OIC) Drugs Sales Market Share by Type in 2017
Table United States Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Opioid Induced Constipation (OIC) Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Opioid Induced Constipation (OIC) Drugs by Type (2013-2018)
Figure Revenue Market Share of Opioid Induced Constipation (OIC) Drugs by Type in 2017
Table United States Opioid Induced Constipation (OIC) Drugs Price (USD/Pcs) by Types (2013-2018)
Figure United States Opioid Induced Constipation (OIC) Drugs Sales Growth Rate by Type (2013-2018)
Table United States Opioid Induced Constipation (OIC) Drugs Sales (K Pcs) by Application (2013-2018)
Table United States Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2013-2018)
Figure United States Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application (2013-2018)
Figure United States Opioid Induced Constipation (OIC) Drugs Sales Market Share by Application in 2017
Table United States Opioid Induced Constipation (OIC) Drugs Sales Growth Rate by Application (2013-2018)
Figure United States Opioid Induced Constipation (OIC) Drugs Sales Growth Rate by Application (2013-2018)
Table Ironwood Pharmaceuticals Inc Basic Information List
Table Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2013-2018)
Figure Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Market Share in United States (2013-2018)
Figure Ironwood Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Revenue Market Share in United States (2013-2018)
Table Daiichi Sankyo Co Ltd Basic Information List
Table Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2013-2018)
Figure Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Sales Market Share in United States (2013-2018)
Figure Daiichi Sankyo Co Ltd Opioid Induced Constipation (OIC) Drugs Revenue Market Share in United States (2013-2018)
Table Pfizer Basic Information List
Table Pfizer Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Pfizer Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2013-2018)
Figure Pfizer Opioid Induced Constipation (OIC) Drugs Sales Market Share in United States (2013-2018)
Figure Pfizer Opioid Induced Constipation (OIC) Drugs Revenue Market Share in United States (2013-2018)
Table Progenics Pharmaceuticals Inc Basic Information List
Table Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2013-2018)
Figure Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Sales Market Share in United States (2013-2018)
Figure Progenics Pharmaceuticals Inc Opioid Induced Constipation (OIC) Drugs Revenue Market Share in United States (2013-2018)
Table Shionogi & Co., Ltd Basic Information List
Table Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2013-2018)
Figure Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Sales Market Share in United States (2013-2018)
Figure Shionogi & Co., Ltd Opioid Induced Constipation (OIC) Drugs Revenue Market Share in United States (2013-2018)
Table Allergan Plc Basic Information List
Table Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2013-2018)
Figure Allergan Plc Opioid Induced Constipation (OIC) Drugs Sales Market Share in United States (2013-2018)
Figure Allergan Plc Opioid Induced Constipation (OIC) Drugs Revenue Market Share in United States (2013-2018)
Table Nektar Therapeutics Basic Information List
Table Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2013-2018)
Figure Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Sales Market Share in United States (2013-2018)
Figure Nektar Therapeutics Opioid Induced Constipation (OIC) Drugs Revenue Market Share in United States (2013-2018)
Table Purdue Pharma Basic Information List
Table Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2013-2018)
Figure Purdue Pharma Opioid Induced Constipation (OIC) Drugs Sales Market Share in United States (2013-2018)
Figure Purdue Pharma Opioid Induced Constipation (OIC) Drugs Revenue Market Share in United States (2013-2018)
Table S.L.A. Pharma AG Basic Information List
Table S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2013-2018)
Figure S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Sales Market Share in United States (2013-2018)
Figure S.L.A. Pharma AG Opioid Induced Constipation (OIC) Drugs Revenue Market Share in United States (2013-2018)
Table Mundipharma International Limited Basic Information List
Table Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales Growth Rate (2013-2018)
Figure Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Sales Market Share in United States (2013-2018)
Figure Mundipharma International Limited Opioid Induced Constipation (OIC) Drugs Revenue Market Share in United States (2013-2018)
Table Ono Pharmaceutical Co., Ltd Basic Information List
Table Takeda Pharmaceutical Company Limited Basic Information List
Table Theravance Biopharma Inc Basic Information List
Table Valeant Pharmaceuticals International Basic Information List
Table Cosmo Pharmaceuticals SA Basic Information List
Table Daewoong Pharmaceutical Basic Information List
Table C.B. Fleet Company Basic Information List
Table Sucampo Pharmaceuticals Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Opioid Induced Constipation (OIC) Drugs
Figure Manufacturing Process Analysis of Opioid Induced Constipation (OIC) Drugs
Figure Opioid Induced Constipation (OIC) Drugs Industrial Chain Analysis
Table Raw Materials Sources of Opioid Induced Constipation (OIC) Drugs Major Players/Suppliers in 2017
Table Major Buyers of Opioid Induced Constipation (OIC) Drugs
Table Distributors/Traders List
Figure United States Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Opioid Induced Constipation (OIC) Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Opioid Induced Constipation (OIC) Drugs Price (USD/Pcs) Trend Forecast (2018-2025)
Table United States Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) Forecast by Type (2018-2025)
Figure United States Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) Forecast by Type in 2025
Table United States Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) Forecast by Application (2018-2025)
Figure United States Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) Forecast by Application in 2025
Table United States Opioid Induced Constipation (OIC) Drugs Sales Volume (K Pcs) Forecast by Region (2018-2025)
Table United States Opioid Induced Constipation (OIC) Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Opioid Induced Constipation (OIC) Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Opioid Induced Constipation (OIC) Drugs Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

More Publications

Need Help?

Ask a Question

Market Reports

All Categories